<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36216527</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>15</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Teaching Video NeuroImage: Disabling Jaw Clonus in a Patient With Bulbar-Onset Amyotrophic Lateral Sclerosis Successfully Treated With Botulinum Toxin.</ArticleTitle><Pagination><StartPage>671</StartPage><MedlinePgn>671</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000201114</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oliveira Santos</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8290-0410</Identifier><AffiliationInfo><Affiliation>From the Department of Neurosciences and Mental Health (M.O.S., M.S., A.V., M.d.C.), Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte; and Institute of Physiology (M.O.S., M.d.C.), Instituto de Medicina Molecular-JLA, Faculdade de Medicina, Universidade de Lisboa, Portugal. migueloliveirasantos@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xf6;n</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2354-9907</Identifier><AffiliationInfo><Affiliation>From the Department of Neurosciences and Mental Health (M.O.S., M.S., A.V., M.d.C.), Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte; and Institute of Physiology (M.O.S., M.d.C.), Instituto de Medicina Molecular-JLA, Faculdade de Medicina, Universidade de Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valadas</LastName><ForeName>Anabela</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6359-6110</Identifier><AffiliationInfo><Affiliation>From the Department of Neurosciences and Mental Health (M.O.S., M.S., A.V., M.d.C.), Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte; and Institute of Physiology (M.O.S., M.d.C.), Instituto de Medicina Molecular-JLA, Faculdade de Medicina, Universidade de Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Carvalho</LastName><ForeName>Mamede</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7556-0158</Identifier><AffiliationInfo><Affiliation>From the Department of Neurosciences and Mental Health (M.O.S., M.S., A.V., M.d.C.), Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte; and Institute of Physiology (M.O.S., M.d.C.), Instituto de Medicina Molecular-JLA, Faculdade de Medicina, Universidade de Lisboa, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.24.69</RegistryNumber><NameOfSubstance UI="D019274">Botulinum Toxins, Type A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019274" MajorTopicYN="Y">Botulinum Toxins, Type A</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012021" MajorTopicYN="N">Reflex, Abnormal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012798" MajorTopicYN="Y">Sialorrhea</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>10</Day><Hour>21</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36216527</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000201114</ArticleId><ArticleId IdType="pii">WNL.0000000000201114</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>